Skip to content
★ Sign in to follow
RC

Roger C. Lucas

Executive
BIO-TECHNE CorpChemoCentryx, Inc.
Total declarations
85
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (61 ops.)
€7.8M

Latest filing published 08 Mar 2019 for ChemoCentryx, Inc..

Filing timeline

BuySale
Roger C. Lucas

Insider track record

Disclosed buys
0
Disclosed sells
61
Signal history

Roger C. Lucas: trading record in brief

Filings by Roger C. Lucas span 2 companies, the busiest being BIO-TECHNE Corp and ChemoCentryx, Inc. The record holds 85 filings, for trades running from 1 February 2006 to 5 March 2019.

Every open-market trade on record is a sale: 61 sales worth €7.8M. The rest of the record consists of 5 share grants and 18 option exercises.

Most recently, on 8 March 2019, the filings show an option exercise in ChemoCentryx, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Roger C. Lucas

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations84 total
  • ◇
    DirectorExecutivesChemoCentryx, Inc.
    0SEC
    8,421 shares0Common StockSEC:0001209191-19-018291:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    12,196 USD11SEC
    100 shares@ US$121.961.4% of flowCommon StockSEC:0001562180-17-003253:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    12,094 USD23SEC
    100 shares@ US$120.941.4% of flowCommon StockSEC:0001562180-17-002935:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    11,430 USD11SEC
    100 shares@ US$114.301.4% of flowCommon StockSEC:0001562180-17-002667:0
  • ▼
    DirectorExecutivesChemoCentryx, Inc.
    22,658 USD25SEC
    2,250 shares@ US$10.0716.9% of flowCommon StockSEC:0001209191-17-047492:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    11,686 USD11SEC
    100 shares@ US$116.861.4% of flowCommon StockSEC:0001562180-17-002467:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    11,362 USD26SEC
    100 shares@ US$113.621.4% of flowCommon StockSEC:0001562180-17-002258:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    116,501 USD27SEC
    1,059 shares@ US$110.0114.5% of flowCommon StockSEC:0001562180-17-002110:0
  • ◆
    DirectorExecutivesChemoCentryx, Inc.
    0SEC
    12,912 shares0Common StockSEC:0001209191-17-036280:0
  • ◇
    DirectorExecutivesChemoCentryx, Inc.
    0SEC
    20,362 shares0Common StockSEC:0001209191-17-036280:1
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    11,059 USD11SEC
    100 shares@ US$110.591.4% of flowCommon StockSEC:0001562180-17-001934:0
  • ▼
    DirectorExecutivesChemoCentryx, Inc.
    29,240 USD13SEC
    4,000 shares@ US$7.3123.6% of flowCommon StockSEC:0001209191-17-029817:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    2,227 USD11SEC
    22 shares@ US$101.230.3% of flowCommon StockSEC:0001562180-17-001502:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    7,888 USD11SEC
    78 shares@ US$101.131.0% of flowCommon StockSEC:0001562180-17-001502:1
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    8,513 USD11SEC
    79 shares@ US$107.761.1% of flowCommon StockSEC:0001562180-17-001257:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    2,264 USD11SEC
    21 shares@ US$107.810.3% of flowCommon StockSEC:0001562180-17-001257:1
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    10,260 USD11SEC
    100 shares@ US$102.601.3% of flowCommon StockSEC:0001562180-17-000678:0
  • ▼
    DirectorExecutivesChemoCentryx, Inc.
    29,280 USD25SEC
    4,000 shares@ US$7.3223.9% of flowCommon StockSEC:0001209191-17-007763:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    10,357 USD11SEC
    100 shares@ US$103.571.4% of flowCommon StockSEC:0001562180-17-000230:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    10,892 USD23SEC
    100 shares@ US$108.921.4% of flowCommon StockSEC:0000914190-16-000956:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    10,575 USD11SEC
    100 shares@ US$105.751.4% of flowCommon StockSEC:0000914190-16-000872:0
  • ▼
    DirectorExecutivesChemoCentryx, Inc.
    24,400 USD13SEC
    4,000 shares@ US$6.1019.6% of flowCommon StockSEC:0001209191-16-148239:0
  • ◆
    DirectorExecutivesBIO-TECHNE Corp
    0SEC
    914 shares0Common StockSEC:0000914190-16-000864:1
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    10,471 USD11SEC
    100 shares@ US$104.711.3% of flowCommon StockSEC:0000914190-16-000864:0
  • ▼
    DirectorExecutivesBIO-TECHNE Corp
    10,891 USD29SEC
    100 shares@ US$108.911.4% of flowCommon StockSEC:0000914190-16-000839:0

25 of 84 declarations